Feasibility of infectious prion digestion using mild conditions and commercial subtilisin.
Two serine protease enzymes, subtilisin 309 and subtilisin 309-v, were used to digest brain homogenates containing high levels of prion infectivity using mildly alkaline conditions to investigate prion decontamination methods. To establish that PrP(res) infectivity was eliminated, we utilized the Rocky Mountain Laboratory (RML) mouse-adapted scrapie model system for bioassay. Only one digestion condition (subtilisin 309 at 138mAU/ml, 55 degrees C and 14h digestion time pH 7.9) was considered to be highly relevant statistically (P<0.001) compared to control, with 52% of challenged mice surviving until the end of the study period. In contrast, treatment of PrP(res) by autoclaving at 134 degrees C or treatment with hypochlorite at a concentration of 20,000 ppm completely protected mice from prionosis. Further, in vitro assays suggest that potential proteolytic based PrP(res) decontamination methods must use high enzyme concentration, pH values >9.0, and elevated temperatures to be a safely efficacious, thereby limiting applicability on delicate surgical instruments and use in the environment.
Pilon
John L
JL
National Wildlife Research Center, 4101 Laporte Ave., Fort Collins, CO 80521, USA. John.l.pilon@usda.gov
Nash
Paul B
PB
Arver
Terry
T
Hoglund
Don
D
Vercauteren
Kurt C
KC
D000818:Animals; D003666:Decontamination / Q000379:methods*; D004202:Disinfectants / Q000494:pharmacology*; D004203:Disinfection / Q000379:methods*; D006863:Hydrogen-Ion Concentration; D006997:Hypochlorous Acid / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D000072002:Prion Proteins; D011328:Prions / Q000378:metabolism*; D013242:Sterilization / Q000379:methods; D020860:Subtilisin / Q000378:metabolism* / Q000494:pharmacology*
D004202:Disinfectants; D000072002:Prion Proteins; D011328:Prions; C512657:Prnp protein, mouse; D006997:Hypochlorous Acid; D020860:Subtilisin